The crisis over GLP-1 out-of-pocket costs deepens—it’s time for health-care leaders to step up
- Posted on March 4, 2025
- By Fortune
- 2 Views
The crisis over GLP-1 out-of-pocket costs deepens—it’s time for health-care leaders to step up
Wegovy, Zepbound, Saxenda, and other GLP-1 or GIP medications are needlessly out of reach for many Americans.
